1. Hamza, A.H., H.H. Ahmed and H.A. Aglan, 2019. An Overview on Alzheimer's Disease. Lambert Academic Publishing, Germany, ISBN-13: 978-613-9-45823-3, Pages: 76.
2. Ahmed, H.H., H.A. Aglan, M. Mabrouk, A.A. Abd-Rabou and H.H. Beherei, 2019. Enhanced mesenchymal stem cell proliferation through complexation of selenium/titanium nanocomposites. J. Mater. Sci.: Mater. Med., Vol. 30, No. 2. 10.1007/s10856-019-6224-z.
   CrossRef  |  Direct Link  |  
3. Aglan, H.A., H.H. Ahmed, N.S. Mahmoud, R.M. Aly, N.A. Ali and A.A. Abd-Rabou, 2019. Nanotechnological applications hold a pivotal position in boosting stem cells osteogenic activity: In vitro and in vivo studies. Applied Biochem. Biotechnol., (In Press). 10.1007/s12010-019-03105-y.
   CrossRef  |  Direct Link  |  
4. Matloub, A.A., A.H. Salama, H.A. Aglan, M.M. AbouSamra, S.S.M. ElSouda and H.H. Ahmed, 2018. Exploiting bilosomes for delivering bioactive polysaccharide isolated from Enteromorpha intestinalis for hacking hepatocellular carcinoma. Drug Dev. Ind. Pharm., 44: 523-534.
   CrossRef  |  Direct Link  |  
5. Aglan, H.A., M. Mabrouk, R.M. Aly, H.H. Beherei and H.H. Ahmed, 2018. Harnessing the antioxidant property of cerium andyttrium oxide nanoparticles to enhance mesenchymal stem cell proliferation. Asian J. Pharm. Clin. Res., 11: 436-442.
   Direct Link  |  
6. Ahmed, H.H., M.D.A. El-Maksoud, A.E.A. Moneim and H.A. Aglan, 2017. Pre-clinical study for the antidiabetic potential of selenium nanoparticles. Biol. Trace Element Res., 177: 267-280.
   Direct Link  |  
7. Aglan, H.A., H.H. Ahmed, S.A. El-Toumy and N.S. Mahmoud, 2017. Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study. Tumor Biol., Vol. 39. 1010428317699127.
   CrossRef  |  Direct Link  |  
8. Salem, N.A., H.H. Ahmed, H.A. Aglan and S.A. ElShebiney, 2016. Nanofiber-expanded stem cells mitigate liver fibrosis: Experimental study. Tissue Cell, 48: 544-551.
   CrossRef  |  Direct Link  |  
9. Salem, N.A., H.H. Ahmed, H.A. Aglan and S.A. ElShebiney, 2016. Multi-targeted therapy of hepatic fibrosis by adipose tissue derived mesenchymal stem cells. Int. J. Pharm. Clin. Res., 8: 640-648.
   Direct Link  |  
10. Matloub, A.A., H.A. Aglan, S.S.M. ElSouda, A.S. Maghraby, M.E. Aboutabl and H.H. Ahmed, 2016. Influence of bioactive sulphated polysaccharide-protein complexes on hepatocarcinogenesis, angiogenesis and immunomodulatory activities. Asian Pac. J. Trop. Med., 10.1016/j.apjtm.2016.11.004.
    CrossRef  |  Direct Link  |  
11. Matloub, A.A., H.A. Aglan, S.S.M. El Souda, M.E. Aboutabl, A.S. Maghraby and H.H. Ahmed, 2016. Influence of bioactive sulfated polysaccharide-protein complexes on hepatocarcinogenesis, angiogenesis and immunomodulatory activities. Asian Pac. J. Trop. Med., 9: 1200-1211.
    CrossRef  |  Direct Link  |  
12. Ahmed, H.H., M.M. Fateheya, A.A. Hadeer and H.A. Sayed, 2016. Exploring potential mechanisms of action of mesenchymal stem cells in Parkinson's disease: In vivo study. Int. J. Curr. Pharm. Rev. Res., 7: 275-282.
13. Ahmed, H.H., M.D.A. El-Maksoud, A.E.A. Moneim and H.A. Aglan, 2016. Pre-clinical study for the anti-diabetic potential of selenium nanoparticles. Biol. Trace Elem. Res., 10.1007/s12011-016-0876-z.
    CrossRef  |  Direct Link  |  
14. Ahmed, H.H., H.A. Aglan, A.M. Zaazaa, A.B. Shalby and S.A. El Toumy, 2016. Quercetin confers tumoricidal activity through multipathway mechanisms in a n-methylnitrosourea rat model of colon cancer. Asian Pac. J. Cancer Prev., 17: 4991-4998.
    CrossRef  |  Direct Link  |  
15. Ahmed, H.H., H.A. Aglan and A.A. Abd-Rabou, 2016. Stem Cells and Neurodegenerative Diseases. In: Developmental and Stem Cell Biology in Health and Disease, El-Hashash, A. (Ed.)., Bentham Science, USA., ISBN: 978-1-68108-220-2, pp: 165-191.
16. Ahmed, H.H., E.R.A. Raouf, L.A. Rashed and H.A. Aglan, 2016. New approaches in the horizon for treatment of Alzheimer`s disease. Der Pharma. Lett., 8: 158-166.
17. Ahmed, H.H., A.M. Salem, H.M. Atta, E.F. Eskandar and A.R.H. Farrag et al., 2016. Updates in the pathophysiological mechanisms of Parkinson`s disease: Emerging role of bone marrow mesenchymal stem cells. World J. Stem Cells, 8: 106-117.
    CrossRef  |  Direct Link  |  
18. Ahmed, H.H., F.M. Metwally, W.K.B. Khalil and H.A. Aglan, 2015. Bone marrow derived mesenchymal stem cells: A unique cytotherapy for rescuing degenerated dopaminergic neurons. Neurochemical J., (In Press). .
19. Ahmed, H.H., F.M. Metwally, W.K.B. Khalil and H.A. Aglan, 2015. Bone marrow derived mesenchymal stem Cells: A unique cytotherapy for rescuing degenerated dopaminergic neurons. Neurochem. J., 9: 284-294.
    CrossRef  |  Direct Link  |  
20. Aglan, H., H. Ahmed and H. Atta, 2015. Cell Therapy in Neurodegenerative Diseases: Mesenchymal Stem Cells and Neurodegeneration. LAP Lambert Academic Publishing, Germany, ISBN: 978-3-659-39739-4, Pages: 428.
21. Salem, A.M., H.H. Ahmed, H.M. Atta, M.A. Ghazy and H.A. Aglan, 2014. Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats. Cell Biol. Int., 38: 1367-1383.
    CrossRef  |  Direct Link  |  
22. Ahmed, H.H., A.M. Salem, H.M. Atta, M.A. Ghazy and H.A. Aglan, 2014. Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model? Hum. Exp. Toxicol., 33: 1217-1231.
    CrossRef  |  Direct Link  |  
23. Salem, A.M., G.M. Sabry, M.M. Abd-ElHalem and H.A. Aglan, 2009. Synthesis of estrogen derivatives with anti-osteoporosis activity. Egypt. Med. J. Natl. Res. Centre, 8: 25-39.